Skip to main content
. 2023 May 17;45(5):4375–4388. doi: 10.3390/cimb45050278

Figure 6.

Figure 6

Evaluation of lung metastases between the control and CBX treatment groups. (a) Hematoxylin and eosin staining. Metastatic nodules were counted. (b) The number of lesions in the lungs of the control group was significantly higher than that of the CBX treatment group.